UMB Bank’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.7K Buy
572
+33
+6% +$764 ﹤0.01% 1800
2026
Q1
$11.1K Sell
539
-46
-8% -$1.04K ﹤0.01% 1819
2025
Q4
$13.9K Buy
585
+268
+85% +$6.52K ﹤0.01% 1689
2025
Q3
$7.89K Sell
317
-65
-17% -$1.4K ﹤0.01% 1762
2025
Q2
$8.79K Buy
382
+45
+13% +$1.04K ﹤0.01% 1648
2025
Q1
$7.57K Buy
337
+115
+52% +$2.67K ﹤0.01% 1637
2024
Q4
$4.34K Sell
222
-19
-8% -$377 ﹤0.01% 1755
2024
Q3
$4.39K Buy
241
+157
+187% +$3K ﹤0.01% 1773
2024
Q2
$1.46K Buy
84
+44
+110% +$779 ﹤0.01% 1880
2024
Q1
$784 Buy
+40
New +$845 ﹤0.01% 1855

Other funds holding PRVA

UMB Bank's PRVA Position: Q2 2026 in Review

UMB Bank increased its Privia Health (PRVA) stake by 6.1% in Q2 2026, buying an estimated $764 and bringing the position to 572 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1800.

UMB Bank first reported a position in PRVA in Q1 2024 and has held it in 10 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • UMB Bank held 572 shares of Privia Health worth $14.7K as of Q2 2026.
  • UMB Bank bought 33 Privia Health shares in Q2 2026, an estimated $764.
  • Privia Health made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1800 holding.
  • UMB Bank first reported a position in Privia Health in Q1 2024 and has held it in 10 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.